logo for Spruce Biosciences

Spruce Biosciences

Business Services · California, United States · 31 Employees

View Company Info for Free

About

Headquarters

611 Gateway Blvd Ste 740, South San Francisco, ...

Phone Number

(415) 655-4168

Revenue

$7.4 Million

Stock Symbol

SPRB

Industry

Business Services General Business Services

Highlights

$251.6M

Total Funding Amount

$53.6M

Most Recent Funding Amount

4

Number of Funding Rounds

Who is Spruce Biosciences

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorderswith significant unmet medical need. Spruce is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy for patients suffering from classic congenital adrenal hyperplasia (CAH). Classic CAH is a serious and life-threatening disease with no known novel therapies approved in approximately 50 years. Spruce is also developing tildacerfont for women suffering from a rare form of polycystic ovary syndrome (PCOS) with primary adrenal androgen excess.Read more

Spruce Biosciences's Social MediaPopular Searchesspruce biosciences IncSpruce BiosciencesSpruce'sSprucebiosciencesSIC Code 28,283NAICS Code 54,541Ticker NASDAQ: SPRBShow more

Spruce Biosciences Org Chart

PhoneEmail
Samir Gharib
Samir Gharib

President & Chief Financial Officer

PhoneEmail
Will Charlton
Will Charlton

Chief Medical Officer

PhoneEmail

PhoneEmail

Similar Companies to Spruce Biosciences

  1. <25
    <$5M

    1

  2. <25
    $12M

    2

  3. <25
    <$5M

    3

  4. 76
    $20.6M

    4

  5. <25
    <$5M

    5

  6. 39
    $5.7M

    6

See more similar companies

Spruce Biosciences Company Metrics

Company Insights
Employee Growth Rate
Funding
Funding DateFeb 09, 2023
RoundShare Placement
Amount$53.6M
Investors5AM Ventures, HealthCap Partners, Rock Springs Capital, Armistice Capital, RiverVest Venture Partners, Abingworth, Novo Holdings
Funding DateOct 09, 2020
RoundStock Issuance/Offering
Amount$90M
Investors
Funding DateFeb 20, 2020
RoundSeries B
Amount$88M
InvestorsOmega Funds, Abingworth LLP, HealthCap Partners LLC, RiverVest Venture Partners, Aisling Capital LLC, Rock Springs Capital LLC, Novo Holdings, Sands Capital Management
See More

$251.6M

Total Funding Amount

$53.6M

Most Recent Funding Amount

4

Number of Funding Rounds

Spruce Biosciences Tech Stack

A closer look at the technologies used by Spruce Biosciences

Top Companies in United States

Top 10 companies in United States by revenue

Top 10 companies in United States by number of employees

Top 10 companies in United States by total funding amount

See top companies

Spruce Biosciences News & Media

  • Spruce Biosciences Recognized as a Bay Area Best Place to Work

    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for endocrine and neurological disorders with significant unmet medical need, announced that the San Francisco Business Times and the Silicon Valley Business Journal have recognized the company as a Best Place to Work in 2024. “We are thrilled to be named as a Best Place to Work in the Bay Area, which is a testame
  • Nano-Cap Spruce Biosciences Collaborates With HMNC Brain Health To Develop Treatment for Major Depressive Disorder

    Spruce Biosciences Inc. (NASDAQ:SPRB) and HMNC Brain Health GmbH have collaborated to develop Spruce’s investigational product candidate, tildacerfont, and HMNC’s companion diagnostic, the proprietary Cortibon Genetic Selection Tool for major depressive disorder (MDD). Spruce Biosciences is a late-stage biopharmaceutical company developing its wholly-owned product candidate, tildacerfont, for classic congenital adrenal hyperplasia, polycystic ovary syndrome, and MDD. “We believe that Cortibon ha
  • Spruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD)

    SOUTH SAN FRANCISCO, Calif. & MUNICH--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB) (“Spruce”), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for endocrine and neurological disorders with significant unmet medical need, and HMNC Brain Health GmbH (“HMNC”), a global precision psychiatry biopharma company, announced today a strategic collaboration to develop Spruce’s investigational product candidate, tildacerfont, a second-generation
  • Spruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024

    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for endocrine disorders with significant unmet medical need, presented results from its Phase 2 POWER study of tildacerfont, a second-generation CRF1 receptor antagonist, for the treatment of polycystic ovary syndrome (PCOS) at the 2024 Annual Meeting of the Endocrine Society (ENDO 2024). “There is a significant u
  • Spruce Biosciences to Participate in the Jefferies Global Healthcare Conference

    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, will present at the Jefferies Global Healthcare Conference on June 5, 2024, at 5:00 p.m. ET. Interested parties can access the live webcast here. An archived copy of the
Read more news

Frequently Asked Questions regarding Spruce Biosciences

Where is Spruce Biosciences located?
Spruce Biosciences's headquarters are located at 611 Gateway Blvd Ste 740, South San Francisco, California, 94080, United States
What is Spruce Biosciences's phone number?
Spruce Biosciences's phone number is (415) 655-4168
What is Spruce Biosciences's stock symbol?
Spruce Biosciences's stock symbol is SPRB
What is Spruce Biosciences's official website?
Spruce Biosciences's official website is www.sprucebiosciences.com
What is Spruce Biosciences's Revenue?
Spruce Biosciences's revenue is $7.4 Million
What is Spruce Biosciences's SIC code?
Spruce Biosciences's SIC: 28,283
What is Spruce Biosciences's NAICS code?
Spruce Biosciences's NAICS: 54,541
How many employees does Spruce Biosciences have?
Spruce Biosciences has 31 employees
What industry does Spruce Biosciences belong to?
Spruce Biosciences is in the industry of: Business Services General, Business Services
What is Spruce Biosciences competition?
Spruce Biosciences top competitors include: Relmada Therapeutics, TRACON Pharma, Imara, Annexon Biosciences
What technology does Spruce Biosciences use?
Some of the popular technologies that Spruce Biosciences uses are: goo.gl, WordPress.org, Drupal, reCAPTCHA
Who is the CFO of Spruce Biosciences?
Spruce Biosciences's CFO is Samir Gharib
How do I contact Spruce Biosciences?
Spruce Biosciences contact info: Phone number: (415) 655-4168 Website: www.sprucebiosciences.com
What does Spruce Biosciences do?

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. Spruce is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy for patients suffering from classic con... genital adrenal hyperplasia (CAH). Classic CAH is a serious and life-threatening disease with no known novel therapies approved in approximately 50 years. Spruce is also developing tildacerfont for women suffering from a rare form of polycystic ovary syndrome (PCOS) with primary adrenal androgen excess.Read More

What are Spruce Biosciences social media links?
Spruce Biosciences Linkedin page Spruce Biosciences Twitter page Spruce Biosciences Facebook page
How much funding has Spruce Biosciences raised to date?
Spruce Biosciences has raised $251.6 Million in 4 funding rounds
When was the last funding round for Spruce Biosciences?
Spruce Biosciences closed its last funding round on Feb 09, 2023 with the amount of $53.6 Million
Who invested in Spruce Biosciences?
Spruce Biosciences has 17 investors including Rock Springs Capital LLC, Novo Holdings, Sands Capital Management and Novo Holdings.
Is Spruce Biosciences a public company?
Yes, Spruce Biosciences is a public company and is traded under the symbol SPRB
See more information about Spruce Biosciences

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.